Alternatives to Exobiosphere

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing novel therapies to reverse aging and extend lifespan.

Advancing next-generation mRNA medicines.